Longitude (Cayman) Ltd. Acadia Pharmaceuticals Inc Call Options Transaction History

Longitude (Cayman) Ltd.

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 12, 2022	SELL	$20.94 - $27.5 $628,200 - $825,000	-30,000 Reduced 66.67%	15,000 $363,000
Q4 2021 Feb 03, 2022	SELL	$16.79 - $27.09 $587,650 - $948,150	-35,000 Reduced 43.75%	45,000 $1.05 Million
Q3 2021 Nov 08, 2021	BUY	$15.78 - $24.77 $1.1 Million - $1.73 Million	70,000 Added 700.0%	80,000 $1.33 Million
Q1 2021 May 11, 2021	BUY	$25.02 - $54.99 $250,200 - $549,900	10,000 New	10,000 $258,000

280

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.62B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Longitude (Cayman) Ltd., based on Form 13F filings with the SEC.

Stay updated on Longitude (Cayman) Ltd. with notifications on news.